We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents New Fully Automated Sample to Result System for Diagnosis of Viral Infections

By LabMedica International staff writers
Posted on 15 Nov 2022

Sentinel Diagnostics (Milano, Italy) is presenting its newly-launched SENTiNAT 200 fully automated sample to result system, and STAT-NAT SN200 Real-Time PCR assays for the quantitative detection of 10 viruses at MEDICA 2022. More...

The new SENTiNAT 200 and STAT-NAT SN200 kits represent the ideal solution for mid to large throughput laboratories engaged in the diagnosis of viral infections.

SENTiNAT 200 is a compact platform for DNA/RNA extraction, PCR set up and amplification that includes two integrated thermal cyclers and the FastFinder analysis software. The system combines throughput, automation and flexibility to better adapt to the various laboratory needs. It performs multi-parametric analysis of up to 15 viruses in the same run, processing from one up to 48 samples in four hours. The intuitive software that guides the operator through all the phases of the instrument set up, along with the barcode reader for samples and reagents help to reduce human error. The operator can access to the data available on the cloud anytime anywhere, to optimize reporting time while maintaining full control over the results.

SENTiNAT 200 is designed to work with STAT-NAT SN200 kits, based on the freeze-dried patented technology that allows long term stability at room temperature, making the assays more robust and simplifying reagent management in the laboratory. Also on display at the Sentinel booth at MEDICA 2022 is the recently launched SENTiFIT 800 high-throughput and fully automated solution for fecal immunochemical tests. SENTiFIT 800 represents the solution to help laboratories in the diagnosis of CRC as well as other digestive diseases.

“We developed the SENTiNAT 200 and STAT-NAT SN200 kits, all CE-marked, to offer a complete solution, that simplifies the routine activities of virology laboratories, including those dedicated to transplant patient,” said Marco Buonaguidi, Head of Sales and Marketing. “Today, we take a first step on a path that will see us committed to developing new parameters to satisfy the most challenging requests of our clients in molecular diagnostics.”

Related Links:
Sentinel Diagnostics 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.